ScinoPharm Taiwan Ltd
TWSE:1789
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
TW |
|
Zepp Health Corp
NYSE:ZEPP
|
CN |
|
I
|
Inter RAO Lietuva AB
WSE:IRL
|
LT |
|
H
|
Hera SpA
XBER:HE9
|
IT |
|
Lincoln Gold Mining Inc
XTSX:LMG
|
CA |
|
C
|
Compal Electronics Inc
LSE:CEIR
|
TW |
|
Grom Social Enterprises Inc
NASDAQ:GROM
|
US |
Wall Street
Price Targets
Price Targets Summary
ScinoPharm Taiwan Ltd
According to Wall Street analysts, the average 1-year price target for
ScinoPharm Taiwan Ltd
is 27.03 TWD
with a low forecast of 26.77 TWD and a high forecast of 27.83 TWD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ScinoPharm Taiwan Ltd's stock price target?
Price Target
27.03
TWD
According to Wall Street analysts, the average 1-year price target for
ScinoPharm Taiwan Ltd
is 27.03 TWD
with a low forecast of 26.77 TWD and a high forecast of 27.83 TWD.
What is ScinoPharm Taiwan Ltd's Revenue forecast?
Projected CAGR
17%
For the last 14 years the
compound annual growth rate for
ScinoPharm Taiwan Ltd's revenue is
-2%.
The projected
CAGR
for the next 1 year is
17%.
What is ScinoPharm Taiwan Ltd's Operating Income forecast?
Projected CAGR
321%
For the last 14 years the
compound annual growth rate for
ScinoPharm Taiwan Ltd's operating income is
-15%.
The projected
CAGR
for the next 1 year is
321%.
What is ScinoPharm Taiwan Ltd's Net Income forecast?
Projected CAGR
209%
For the last 14 years the
compound annual growth rate for
ScinoPharm Taiwan Ltd's net income is
-13%.
The projected
CAGR
for the next 1 year is
209%.
